School of Clinical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Centre for Biomedical Technologies, Queensland University of Technology, Brisbane, QLD, Australia.
PLoS One. 2023 Feb 2;18(2):e0280765. doi: 10.1371/journal.pone.0280765. eCollection 2023.
Computed tomography (CT) derived Monte Carlo (MC) phantoms allow dose determination within small animal models that is not feasible with in-vivo dosimetry. The aim of this study was to develop a CT-derived MC phantom generated from a mouse with a xenograft tumour that could then be used to calculate both the dose heterogeneity in the tumour volume and out of field scattered dose for pre-clinical small animal irradiation experiments. A BEAMnrc Monte-Carlo model has been built of our irradiation system that comprises a lead collimator with a 1 cm diameter aperture fitted to a Cs-137 gamma irradiator. The MC model of the irradiation system was validated by comparing the calculated dose results with dosimetric film measurement in a polymethyl methacrylate (PMMA) phantom using a 1D gamma-index analysis. Dose distributions in the MC mouse phantom were calculated and visualized on the CT-image data. Dose volume histograms (DVHs) were generated for the tumour and organs at risk (OARs). The effect of the xenographic tumour volume on the scattered out of field dose was also investigated. The defined gamma index analysis criteria were met, indicating that our MC simulation is a valid model for MC mouse phantom dose calculations. MC dose calculations showed a maximum out of field dose to the mouse of 7% of Dmax. Absorbed dose to the tumour varies in the range 60%-100% of Dmax. DVH analysis demonstrated that tumour received an inhomogeneous dose of 12 Gy-20 Gy (for 20 Gy prescribed dose) while out of field doses to all OARs were minimized (1.29 Gy-1.38 Gy). Variation of the xenographic tumour volume exhibited no significant effect on the out of field scattered dose to OARs. The CT derived MC mouse model presented here is a useful tool for tumour dose verifications as well as investigating the doses to normal tissue (in out of field) for preclinical radiobiological research.
计算机断层扫描(CT)衍生的蒙特卡罗(MC)体模允许在小动物模型中进行剂量测定,而体内剂量测定则不可行。本研究的目的是开发一种源自带有异种移植物肿瘤的小鼠的 CT 衍生 MC 体模,然后可以使用该体模计算肿瘤体积内的剂量不均匀性和临床前小动物照射实验中的场外散射剂量。我们已经建立了一个 BEAMnrc 蒙特卡罗模型,该模型由一个带有 1 厘米直径孔径的铅准直器组成,该准直器安装在 Cs-137 伽马辐照器上。通过在 PMMA 体模中使用 1D 伽马指数分析比较计算剂量结果与剂量测定膜测量,验证了辐照系统的 MC 模型。在 CT 图像数据上计算并可视化了 MC 小鼠体模中的剂量分布。为肿瘤和危及器官(OAR)生成了剂量体积直方图(DVH)。还研究了异种移植物肿瘤体积对场外散射剂量的影响。定义的伽马指数分析标准得到满足,表明我们的 MC 模拟是 MC 小鼠体模剂量计算的有效模型。MC 剂量计算显示,小鼠场外最大剂量为 Dmax 的 7%。肿瘤吸收剂量在 Dmax 的 60%-100%范围内变化。DVH 分析表明,肿瘤接受了不均匀的 12 Gy-20 Gy 剂量(对于 20 Gy 规定剂量),同时将场外剂量降至最低(1.29 Gy-1.38 Gy)。异种移植物肿瘤体积的变化对 OAR 的场外散射剂量没有显著影响。本文提出的 CT 衍生 MC 小鼠模型是肿瘤剂量验证以及临床前放射生物学研究中正常组织(场外)剂量研究的有用工具。